Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

3 results
Display

Angiotensin converting enzyme inhibitors remain the first treatment of choice

Oh PC, Sakuma I, Hayashi T, Koh KK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypertriglyceridemia and Cardiovascular Diseases: Revisited

Han SH, Nicholls S, Sakuma I, Zhao D, Koh KK

Residual cardiovascular risk and failure of high density lipoprotein cholesterol raising treatment have refocused interest on targeting hypertriglyceridemia. Hypertriglyceridemia, triglyceride-rich lipoproteins, and remnant cholesterol have demonstrated to be important risk...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events

Koh KK, Sakuma I, Shimada K, Hayashi T, Quon MJ

Hypercholesterolemia and hypertension are among the most important risk factors for cardiovascular (CV) disease. They are also important contributors to metabolic diseases including diabetes that further increase CV risk. Updated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr